Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
People with HCV and opioid use disorder have low PrEP uptake, adherence
HIV PrEP uptake and adherence were low among a cohort of people with opioid use disorder who were undergoing treatment for hepatitis C virus, despite many of them meeting CDC criteria for PrEP use, according to a study.
Q&A: Evidence mounts that digital assistant Suki saves physicians hours of EMR time
New data show that Suki, a voice-activated and artificial intelligence-based tool that helps physicians with their note-taking process, continues to dramatically reduce the time that physicians spend on documentation.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: How can PCPs properly manage patients with opioid use disorder?
A new medical education curriculum in an area hit hard by the opioid epidemic will help fill a gap in addiction management training, according to a press release.
MedPAC denies payment increase for physicians in 2023
The Medicare Payment Advisory Commission, or MedPAC, recommended no change to the physician fee schedule for 2023, a decision that the ACP and AMA described as a freezing of physician payments.
COVID-19 pandemic led to more inclusive practices in clinical trials
Clinical trial sponsors said they have adopted new methods and decentralized procedures that may increase diversity and inclusion in future trials.
Q&A: What are physicians’ legal obligations under the Americans with Disabilities Act?
The results of a new survey suggest that many physicians do not completely understand what the Americans with Disabilities Act means for them.
Q&A: Ergonomics key to preventing injury, improving well-being of endoscopists
Optimal ergonomics plays a critical role in preventing endoscopy-related injury by enhancing safety in practice and, thus, extending career lifespans.
For the first time, US faces a blood shortage crisis
The American Red Cross has declared, for the first time, a national blood crisis.
FDA warns of oral health problems linked to transmucosal buprenorphine
The FDA is warning patients and health care professionals that transmucosal buprenorphine products may cause tooth decay, cavities, oral infections and tooth loss, even in patients with no prior history of dental issues.
Hepatology top 10 from 2021: NAFLD management, guideline updates, NASH treatment
Healio presents the following report on the top 10 hepatology peer-tested articles from 2021.
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read